By Josh Beckerman
AquaBounty Technologies said third-quarter product revenue fell to $47,812 from $733,133, while net losses were narrower, primarily due to the sale of its Indiana fish farm.
AquaBounty, which had its first commercial-scale harvest of genetically engineered Atlantic salmon in 2021, said it is reviewing financing initiatives to maintain liquidity and has worked to reduce costs where appropriate.
Net loss was 88 cents a share, compared with a net loss of $1.60 a share a year earlier.
AquaBounty said in September that it would sell its Prince Edward Island facility.
The company says its land-based operations have environmental benefits including reducing imports and helping to protect wild salmon populations.
Stores including Whole Foods and Kroger have said over the years that they won't sell genetically engineered salmon. AquaBounty has noted retailer resistance and expressed more optimism about wholesale customers. Its products also include conventional Atlantic salmon eggs and salmon byproducts.
Shares were down 2.6% to $1.11 in recent trading.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
November 05, 2024 13:34 ET (18:34 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。